Cryoablation of the prostate in high-risk patients with localized prostate cancer

In patients with localized high-risk prostate cancer, according to the recommendations of the European Association of Urology, as well as the Association of Russian Oncologists, the main treatment methods in most cases are radical prostatectomy or radiation therapy (in combination with adjuvant hormone therapy). In some patients, surgical treatment may be limited by age, risk of complications, or refusal to perform surgery. A combination of radiation therapy or brachytherapy with hormone therapy may be an alternative treatment option. These treatment options have a significant risk of developing complications such as urinary incontinence, radiation cystitis and radiation proctitis, etc. Cryoablation is an alternative treatment option in patients with high-risk prostate cancer.